Tekla Life Sciences Investors (HQL) Ownership
HQL ownership summary
as of October 18, 2026- Institutions
- 38.3% of shares outstanding
- Insiders
- 0.00% of shares outstanding
- Shares outstanding
- 30.4M
- Float
- 0 shares available to trade
- Short interest
- — 113K shares short
- Days to cover
- 0.91 short interest up 12.6% vs prior month
- Institutions 38.27%
- Insiders 0.00%
- Other investors 61.73%
HQL insider transactions
latest 16| Date | Name | Transaction | Price | Shares | Value |
|---|---|---|---|---|---|
| 2025-09-22 | Saba Capital Management, L.P. | Sell | $14.14 | 41,623 | $588,549 |
| 2025-09-19 | Saba Capital Management, L.P. | Sell | $14.10 | 6,989 | $98,545 |
| 2025-09-18 | Saba Capital Management, L.P. | Sell | $14.07 | 40,208 | $565,727 |
| 2025-09-17 | Saba Capital Management, L.P. | Sell | $13.99 | 24,328 | $340,349 |
| 2025-09-16 | Saba Capital Management, L.P. | Sell | $13.99 | 2,026 | $28,344 |
| 2025-09-15 | Saba Capital Management, L.P. | Sell | $14.13 | 700 | $9,891 |
| 2025-09-11 | Saba Capital Management, L.P. | Sell | $14.28 | 15,116 | $215,856 |
| 2025-09-02 | Saba Capital Management, L.P. | Sell | $14.04 | 14,083 | $197,725 |
| 2025-08-29 | Saba Capital Management, L.P. | Sell | $13.89 | 23,723 | $329,512 |
| 2025-08-26 | Saba Capital Management, L.P. | Sell | $13.83 | 400 | $5,532 |
| 2025-08-21 | Saba Capital Management, L.P. | Sell | $14.07 | 10,710 | $150,690 |
| 2025-05-20 | Saba Capital Management, L.P. | Sell | $12.71 | 11,419 | $145,135 |
| 2025-05-15 | Saba Capital Management, L.P. | Sell | $12.08 | 23,729 | $286,646 |
| 2025-05-14 | Saba Capital Management, L.P. | Sell | $12.04 | 600 | $7,224 |
| 2025-05-13 | Saba Capital Management, L.P. | Sell | $12.28 | 730 | $8,964 |
| 2025-05-07 | Saba Capital Management, L.P. | Sell | $12.19 | 1,366 | $16,652 |
Reported trades by company officers, directors and other filers (including disclosures by members of Congress where EODHD lists them). "—" where the filing gives no share count.
HQL shares outstanding
Year-end shares outstanding, adjusted for splits.
Who owns HQL
Institutional investors own 38.3% of Tekla Life Sciences Investors's shares and insiders 0.00%. The share count rose 51.9% since 2014.
Related: HQL key metrics, HQL dividend history. See the HQL stock overview for the latest quote and news.
HQL ownership FAQ
What percentage of Tekla Life Sciences Investors is owned by institutions?
Institutions hold 38.3% of Tekla Life Sciences Investors's shares outstanding; insiders hold 0.00%.
Are insiders buying or selling Tekla Life Sciences Investors?
Of the latest 16 reported insider transactions in Tekla Life Sciences Investors (since May 7, 2025), 0 were purchases and 16 were sales.
How many shares of Tekla Life Sciences Investors are outstanding?
Tekla Life Sciences Investors has 30.4M shares outstanding, of which an unreported number are in the public float.